Introduction to Cafergot and Its Role in Migraine Therapy Cafergot is a specialized pharmaceutical preparation that has long served as a cornerstone in the acute treatment of migraine headaches. Characterized by its unique combination of two distinct active pharmacological agents—ergotamine tartrate and caffeine—this medication is designed to address the complex neurovascular changes that occur during […]
Sansert (methysergide maleate) is a serotonin receptor antagonist used to treat migraine headaches. It is one of the oldest and most widely used medications for treating migraine attacks. Sansert has been used since the mid-1960s and was approved for use in the United States in 1981. Sansert works by preventing the release of serotonin, a […]
Introduction to DHE 45 and Dihydroergotamine The proprietary designation DHE 45 serves as a well-established trade name for the pharmaceutical compound dihydroergotamine, a semi-synthetic derivative belonging to the ergot alkaloid family. This pharmacological agent is primarily recognized and utilized in the field of neurology for the acute treatment of moderate to severe migraine headaches, often […]